| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 659687 | 6H-Pyrido[4,3-b]carbazole-1-carboxamide, 9-hydroxy- 5,6-dimethyl-N-[2-(dimethylamino)ethyl]-, dihydrochloride | 0.00211131723826695 | 0.6034799 |
| NSC 736202 | Indenoisoquinoline derivative | 0.00211131723826695 | 0.74849179 |
| NSC 135962 | Aracytidine 5'-palmitate | 0.00211131723826697 | 0.55929581 |
| NSC 166199 | Phosphinic amide, P,P-bis(1-aziridinyl)-N-tricyclo[3.3.1.1(3.7)]dec-1-yl- (9CI) | 0.00211131723826697 | 0.78422753 |
| NSC 633713 | N.ALPHA.-(4-AMINO-4-DEOXYLPTEROYL)-N.DELTA.-HEMIPHTHALOYL-L-ORNITHINE | 0.00216534295403404 | 0.41123964 |
| NSC 693118 | Null | 0.00216534295403404 | 0.53665727 |
| NSC 166237 | Ethanol, 2,2'-[[3-methyl-4-[[[4-(2-methyl-4-thiazolyl)phenyl]imino]methyl]phenyl]imino]bis-, dimethanesulfonate (ester), monohydrochloride (9CI) | 0.00248668807445192 | 0.52347346 |
| NSC 240529 | 2,5-Cyclohexadien-1-one, 4-[[4-[bis(2-chloroethyl)amino]phenyl]imino]-2,6-dimethyl- | 0.00248668807445192 | 0.67395859 |
| NSC 357704 | Cyanomorpholinodoxorubicin | 0.00248668807445192 | 0.69068598 |
| NSC 623520 | Null | 0.00248668807445195 | 0.22721226 |